ArticleVirusdisease2021

Respiratory delivery of favipiravir-tocilizumab combination through mucoadhesive protein-lipidic nanovesicles: prospective therapeutics against COVID-19.

Vikram Thakur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.